IL6 and colitis: Notably, MS inhibited IL-6 production more significantly than TNF-α, especially at the mRNA level, in mouse peritoneal macrophages, which is consistent with our in vivo results of the DSS colitis model, which showed that MS treatment reduced the production of IL-6 by 67–90% compared with control mice.